Overview

Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The time course of response following one dose of a new methylphenidate hydrochloride extended release capsule is studied in children 6-12 years in a simulated laboratory classroom setting. Biphentin methylphenidate hydrochloride extended release capsule has been formulated for daily dosing to provide treatment of a child with ADHD for the substantial day.
Phase:
Phase 3
Details
Lead Sponsor:
Rhodes Pharmaceuticals, L.P.
Treatments:
Methylphenidate